Systematic reviews and meta-analyses of randomized controlled trials have found that GLP-1 receptor agonists significantly decreased CRP levels compared to placebo or other diabetes medications
PlexusDx helps patients and providers understand metabolic predispositions in peptide pathways, enabling more informed conversations about whether GLP-1 therapy aligns with individual recovery goals and physiological state
A review of diabetes treatment adherence and the association with clinical and economic outcomes
PubChem Compound Record for Taurine. Available at: National Center for Biotechnology Information (NCBI)
Never take two doses within three days (72 hours) of each other, as this may increase the risk of adverse effects, particularly gastrointestinal side effects
Whether it's for regenerative medicine, aesthetic enhancement, or surgical procedures, Kealor is your trusted partner in advancing healthcare and beauty